Studies Find Merlin CP-GEP Test Improved Melanoma Risk Stratification
Two peer-reviewed studies demonstrate superior risk stratification compared to traditional clinicopathologic features and competitor testing.
Read MorePosted by CLP Edit Staff | Dec 18, 2025 | Melanoma |
Two peer-reviewed studies demonstrate superior risk stratification compared to traditional clinicopathologic features and competitor testing.
Read MorePosted by CLP Edit Staff | Dec 17, 2025 | Molecular Diagnostic Analyzers |
The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.
Read MorePosted by Alyx Arnett | Dec 17, 2025 | Diagnostic Technologies |
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Read MorePosted by CLP Edit Staff | Dec 17, 2025 | Disease States |
The additions aim to enable earlier detection and treatment of both rare conditions, which typically aren’t diagnosed until ages 4-5.
Read MorePosted by CLP Edit Staff | Dec 16, 2025 | Infectious Diseases |
The collaboration aims to create a non-invasive diagnostic for Pseudomonas aeruginosa using miniaturized gas chromatography-mass spectrometry technology.
Read More